Treatment of glossodynia with olanzapine - 24/08/11
Indianapolis, Indiana
Abstract |
A 73-year-old white male with a 6-month history of glossodynia, unresponsive to clotrimazole troches, cevimeline, triamcinolone dental paste, paroxetine, and lorazepam presented to the dermatology clinic for consultation. Work-up revealed no oral abnormalities and no underlying systemic disorder. He denied symptoms consistent with a psychiatric disorder. A detailed free amnestic assessment by a board certified Geriatric Psychiatrist (John S. Kennedy, MD) found that the patient was oppressed by the pain. He did not meet the criteria for major depression nor did he have any anxiety disorder or delusions. Because of the presence of dysphoria and anticipatory anxiety secondary to glossodynia, the patient was started on olanzapine. Improvement of pain symptoms were noted within 3 days with full resolution of symptoms at 1- and 3-month follow-ups. Dysphoria and anticipatory anxiety remitted fully upon pain relief.
Le texte complet de cet article est disponible en PDF.Plan
Funding sources: None. Conflicts of interest: Frank P. Bymaster, MS, PhD is currently employed in the research laboratory of Eli Lilly and Company. John S. Kennedy, MD was employed by Eli Lilly and Company from 1997-2002, but is now employed by Indiana University School of Medicine. The other two authors are unaffiliated with Eli Lilly and Company and contacted Frank Bymaster, MS, PhD after the patient was seen in follow-up. |
Vol 51 - N° 3
P. 463-465 - septembre 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?